|
Name |
4-Isopropyl-6-methyltetralone
|
Molecular Formula | C14H18O | |
IUPAC Name* |
6-methyl-4-propan-2-yl-3,4-dihydro-2H-naphthalen-1-one
|
|
SMILES |
CC1=CC2=C(C=C1)C(=O)CCC2C(C)C
|
|
InChI |
InChI=1S/C14H18O/c1-9(2)11-6-7-14(15)12-5-4-10(3)8-13(11)12/h4-5,8-9,11H,6-7H2,1-3H3
|
|
InChIKey |
KIZXBPVAPQXAMH-UHFFFAOYSA-N
|
|
Synonyms |
57494-10-7; 10-nor-Calamenen-10-one; 4-Isopropyl-6-methyltetral-1-one; 4-Isopropyl-6-methyltetralone; 4-ISOPROPYL-6-METHYL-1-TETRALONE; 10-Norcalamenene-10-one; CHEMBL4090724; DTXSID60423897; E80189; Q67879560; 4-isopropyl-6-methyl-1,2,3,4-tetrahydronaphthalen-1-one
|
|
CAS | 57494-10-7 | |
PubChem CID | 6429078 | |
ChEMBL ID | CHEMBL4090724 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 202.29 | ALogp: | 3.5 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.659 |
Caco-2 Permeability: | -4.523 | MDCK Permeability: | 0.00001930 |
Pgp-inhibitor: | 0.555 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.035 |
30% Bioavailability (F30%): | 0.934 |
Blood-Brain-Barrier Penetration (BBB): | 0.971 | Plasma Protein Binding (PPB): | 92.16% |
Volume Distribution (VD): | 0.529 | Fu: | 7.64% |
CYP1A2-inhibitor: | 0.36 | CYP1A2-substrate: | 0.93 |
CYP2C19-inhibitor: | 0.805 | CYP2C19-substrate: | 0.878 |
CYP2C9-inhibitor: | 0.659 | CYP2C9-substrate: | 0.823 |
CYP2D6-inhibitor: | 0.056 | CYP2D6-substrate: | 0.673 |
CYP3A4-inhibitor: | 0.3 | CYP3A4-substrate: | 0.584 |
Clearance (CL): | 6.995 | Half-life (T1/2): | 0.162 |
hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.206 |
Drug-inuced Liver Injury (DILI): | 0.426 | AMES Toxicity: | 0.261 |
Rat Oral Acute Toxicity: | 0.141 | Maximum Recommended Daily Dose: | 0.188 |
Skin Sensitization: | 0.044 | Carcinogencity: | 0.431 |
Eye Corrosion: | 0.013 | Eye Irritation: | 0.324 |
Respiratory Toxicity: | 0.633 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001822 | 0.547 | D06GIP | 0.373 | ||||
ENC001821 | 0.547 | D0J6WW | 0.282 | ||||
ENC002065 | 0.527 | D00IUG | 0.269 | ||||
ENC004006 | 0.508 | D06IXT | 0.261 | ||||
ENC006141 | 0.453 | D02LZB | 0.247 | ||||
ENC000165 | 0.429 | D00ZFP | 0.241 | ||||
ENC006142 | 0.389 | D0EL2O | 0.240 | ||||
ENC004005 | 0.379 | D01JMC | 0.238 | ||||
ENC006050 | 0.375 | D01PJR | 0.238 | ||||
ENC001355 | 0.370 | D05VIX | 0.236 |